Schemų terapija - Company finances
|
EUR
|
2024
From: 2024-01-09
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 85,474 | 64,311 |
| Profit before tax | 53,350 | 41,730 |
| Net profit | 53,350 | 39,308 |
| Equity | 53,352 | 92,660 |
| Liabilities | 30 | 3,513 |
| Non-current assets | 0 | 0 |
| Current assets | 53,041 | 95,848 |
| Total assets | 53,041 | 95,848 |
|
Taxes paid
|
||
| STI taxes | 7,094 | 10,352 |
|
Financial indicators
|
||
| Revenue change y/y | - | -24.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.6% | 41.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 42.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 62.4% | 61.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 62.4% | 64.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Schemų terapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-10-01 | 2024-10-31 | 258.00 |
| 2024-09-03 | 2024-09-30 | 193.50 |
| 2024-08-01 | 2024-09-02 | 129.00 |
| 2024-07-02 | 2024-07-31 | 64.50 |
Schemų terapija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Schemu terapija, MB (code 306656530) is a Lithuanian small partnership engaged in other social work activities without accommodation n.e.c. In 2025, the company generated revenue of EUR 64.3 thousand, down 24.8% from EUR 85.5 thousand in 2024. Even with the lower turnover, profitability remained strong: net profit was EUR 39.3 thousand in 2025, compared with EUR 53.4 thousand in 2024, and the profit margin stayed high at 61.1% after 62.4% a year earlier. The balance sheet also strengthened over the year. Total assets increased from EUR 53.0 thousand in 2024 to EUR 95.8 thousand in 2025, while equity rose from EUR 53.4 thousand to EUR 92.7 thousand. Liabilities remained very low at EUR 3.5 thousand at the end of 2025, following EUR 30 in 2024. Key efficiency indicators for 2025 were also solid, with return on equity at 42.4%, return on assets at 41.0%, debt to equity at 0.04, and asset turnover at 0.67x. Revenue per employee cannot be assessed because staff data is not provided.